Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Doxorubicin increases the effectiveness of Apo2L/TRAIL for tumor growth inhibition of prostate cancer xenografts.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Doxorubicin increases the effectiveness of Apo2L/TRAIL for tumor growth inhibition of prostate cancer xenografts.
Doxorubicin increases the effectiveness of Apo2L/TRAIL for tumor growth inhibition of prostate cancer xenografts. BMC Cancer. 2005 Jan 07; 5:2.
View in:
PubMed
subject areas
Animals
Antineoplastic Combined Chemotherapy Protocols
Apoptosis Regulatory Proteins
CASP8 and FADD-Like Apoptosis Regulating Protein
Cell Line, Tumor
Down-Regulation
Doxorubicin
Drug Screening Assays, Antitumor
Drug Synergism
Humans
Intracellular Signaling Peptides and Proteins
Male
Membrane Glycoproteins
Mice
Mice, Nude
Neoplasm Proteins
Prostatic Neoplasms
TNF-Related Apoptosis-Inducing Ligand
Transplantation, Heterologous
Tumor Necrosis Factor-alpha
authors with profiles
Christina Voelkel Johnson